[go: up one dir, main page]

AU2003205499A1 - Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides - Google Patents

Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides

Info

Publication number
AU2003205499A1
AU2003205499A1 AU2003205499A AU2003205499A AU2003205499A1 AU 2003205499 A1 AU2003205499 A1 AU 2003205499A1 AU 2003205499 A AU2003205499 A AU 2003205499A AU 2003205499 A AU2003205499 A AU 2003205499A AU 2003205499 A1 AU2003205499 A1 AU 2003205499A1
Authority
AU
Australia
Prior art keywords
inhalable
macrolides
acute
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003205499A
Inventor
Oktay Menekse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANBICS PATENTS-LICENCES AG
Original Assignee
ANBICS PATENTS LICENCES AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANBICS PATENTS LICENCES AG filed Critical ANBICS PATENTS LICENCES AG
Publication of AU2003205499A1 publication Critical patent/AU2003205499A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003205499A 2003-02-28 2003-02-28 Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides Abandoned AU2003205499A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CH2003/000148 WO2004075874A1 (en) 2003-02-28 2003-02-28 Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides

Publications (1)

Publication Number Publication Date
AU2003205499A1 true AU2003205499A1 (en) 2004-09-17

Family

ID=32913647

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003205499A Abandoned AU2003205499A1 (en) 2003-02-28 2003-02-28 Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides

Country Status (2)

Country Link
AU (1) AU2003205499A1 (en)
WO (1) WO2004075874A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040098023A (en) 2002-03-26 2004-11-18 테바 파마슈티컬 인더스트리즈 리미티드 Drug microparticles
CA2647073A1 (en) * 2006-04-03 2007-10-18 Teva Pharmaceutical Industries Ltd. Drug microparticles
WO2007124382A2 (en) * 2006-04-19 2007-11-01 Novartis Vaccines And Diagnostics, Inc. Inhaled imipenem
CA2665764C (en) 2006-10-11 2015-05-26 Laboratoires Smb S.A. Pharmaceutical anti-infective composition for inhalation
WO2009064469A1 (en) * 2007-11-14 2009-05-22 Nektar Therapeutics Pulmonary delivery of a macrolide antibiotic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
EP1014943B1 (en) * 1997-02-05 2002-06-19 Jago Research Ag Medical aerosol formulations
NZ523693A (en) * 2000-07-10 2004-08-27 Chiron Corp Macrolide formulations for inhalation and methods of treatment of endobronchial infections

Also Published As

Publication number Publication date
WO2004075874A1 (en) 2004-09-10

Similar Documents

Publication Publication Date Title
AU2003273371A1 (en) Transnasal method and catheter for lacrimal system
AU2003238813A1 (en) Implantable bronchial isolation devices and lung treatment methods
EP1605975A4 (en) Composition and method for the treatment and prevention of enteric bacterial infections
AU2002233643A1 (en) Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
PT1565201T (en) Methods of administering dalbavancin for treatment of bacterial infections
WO2004108840A8 (en) Nucleotides for prevention and treatment of bacterial and fungal pathologies
AU2003205499A1 (en) Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides
AU2003244132A1 (en) Method of examining allergic disaese and drug for treating the same
WO2006065301A3 (en) Compositions for treatment of ear infections
AU2003290506A1 (en) Methods and devices for treating severe peripheral bacterial infections
GB0414886D0 (en) Treatment of bacterial infections
AU2002350565A1 (en) Pharmacological targeting of bacterial dna ligase for treatment and prevention of bacterial infections
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2003304316A1 (en) Compounds and methods for the treatment and prevention of bacterial infection
HK1076310A (en) Screeninig and treatment methods for prevention of preterm delivery
HK1100327A (en) Treatment of bacterial infections
HK1067373A (en) Treatment of infections and other disorders
HK1088247A (en) Method of reducing the harmful effects of orally or transdermally delivered nicotine
HU0400015D0 (en) Pharmaceutical combinations especially for the treatment and prevention of urologigal infections and their extragenital complications
HK1071067A (en) Medicament and method for reducing alcohol and/or tobacco consumption
HK1109727A (en) Tetrodotoxin and its derivatives for the treatment of central-nervously derived neuropathic pain
HK1109560A (en) Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain
HK1108616A (en) Device and method for lung treatment
AU2003905718A0 (en) Compound and method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase